Business Wire

Kiln Announces €17 Million in Funding to Expand Staking Offering

28.11.2022 12:00:00 EET | Business Wire | Press release

Share

Today, Kiln announced the close of an €17 million financing round to expand their market-leading staking infrastructure product range. Kiln, the leading enterprise-grade staking technology provider, with over $500 million1 of assets staked under management, received funding from Illuminate Financial with participation by a number of leading crypto investing groups including Consensys, GSR, Kraken Ventures, Leadblock Partners, Sparkle Ventures, XBTO and renewed participation from existing investors 3KVC, Blue Yard Capital, SV Angel and Alven among others.

Kiln believes that the staking market is becoming institutionalized and must move beyond running validators to meet the growing customer need to spread risk. This means creating validator-agnostic APIs and services to enable multi-provider staking. This in turn enables digital assets to be staked wherever they are held, for wallets, custodians, and exchanges. As the industry evolves and the need to integrate multiple staking players proves real, Kiln is in an ideal position to play the aggregator role and accelerate it.

Following the Ethereum network’s transition to a Proof of Stake (PoS) consensus (The Merge) in September, which significantly de-risked the protocol roadmap, Kiln predicts the demand for staking ETH to grow exponentially. Currently, only 12.5%2 of ETH supply is staked, compared to 50-80% for other PoS assets. Plus, with an annual percentage yield on ETH in the 6-7%3 range since the Merge, it offers an attractive return-rate for investors.

Staking is the Web3 industry’s native yield: the yield comes from helping secure the blockchain (validating and proposing blocks), and there is no counterparty risk as in lending, or when dealing with a third-party intermediary such as a centralised exchange.

Laszlo Szabo - Co-Founder & CEO at Kiln, said: “I am thrilled to close a robust funding round with such respected investors in the crypto space which will enable us to build out the next generation market standard in staking technology. At Kiln, we believe it is critical to provide enterprise-grade infrastructure to institutional users, that in turn enables our customers to create new opportunities for their users. We thank our existing and new investors for their partnership. The Kiln team couldn't be more excited about this next stage of building out a world-class staking stack.”

The funding, which includes €17 Million in Series A, will be used to add new features to Kiln’s industry leading product range. Kiln already offers the largest product range dedicated to staking on the market with its focus as a technology provider delivering a simple and validator-agnostic staking stack. This includes:

  • Kiln Connect, which provides a single SDK to integrate staking, rewards data, and your custodian on all major PoS blockchains
  • Kiln On-Chain, which provides smart contracts for seamless ETH staking, any amount of ETH and automated rewards management
  • Kiln Dashboard, which provides a 1-click staking dashboard, administration interface, reporting and data exporting
  • Kiln Validators, a suite of dedicated or shared validators, with enterprise-grade SLAs, deployed on our multi-cloud Kubernetes infrastructure

Kiln’s customers include industry-leading companies such as Binance US, GSR and Ledger.

Rezso Szabo, Partner at Illuminate Financial, said: "We are witnessing a once in a generation change that will catalyze the institutionalisation of Digital Assets. Sophisticated users and institutions need enterprise grade infrastructure. As a thesis-driven investor backed by traditional financial institutions, we believe the Kiln team has demonstrated they can build key infrastructure that is critical for both digital assets native institutions and will also serve as the future rails for financial services infrastructure. We are excited to partner with such a high-calibre team, who are on a mission to raise the bar in B2B infrastructure for the whole ecosystem."

Ciaran O'Leary, Co-Founder and General Partner of BlueYard Capital, added: “Staking is going to be one of the core fabrics of the entire crypto industry. Kiln’s robust, scalable and safe solutions provide an important fabric for large pools of capital to participate in the core functioning of crypto networks and to generate novel forms of yield. We are excited that Kiln is at the forefront of this new market.”

Benoît Bosc, GSR Global Head of Product, said: “Having used Kiln’s infrastructure to stake our own treasury and in the future to offer to our clients, our company’s missions are perfectly aligned. We are delighted to be able to participate in the next stage of Kiln’s development and to contribute to making staking easier and more accessible to everyone.”

Kiln’s unique team is made up of globally recognized experts in the areas of SaaS, blockchain infrastructure and smart contracts. The company is led by its three co-founders: CEO Laszlo Szabo, a serial entrepreneur who was previously the co-founder of tech recruitment firm Skill Hunter and has been accelerating Web3 adoption since 2017, CPO Ernest Oppetit, a former product manager at Improbable and Qubit; and COO Thomas de Phuoc, who was previously the Country Lead for France at Circle.

Kiln comprises industry leaders including Duncan Hoffman, VP Revenue, who previously led the EMEA region for Chainalysis as General Manager and scaled the business through years of growth that led to an $8.6B valuation. Duncan helped establish Chainalysis as the largest SaaS company in the Web3 industry and market-leading solution for cryptocurrency compliance and investigation use cases to help build trust in blockchains.

1

Total as of 11.23.2022

2

As of 11.23.2022 Source: https://beaconcha.in/ and https://etherscan.io/stat/supply

3

Source Rated.network

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Orlagh Lyons, CW8 Communications
Orlagh@cw8-communications.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership30.4.2026 14:00:00 EEST | Press release

CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical program and the strengthening of clinical leadership. Phase 1 of the company’s MOCA II FDA Pivotal Trial was successfully reached after safety and performance goals were met with STEMI heart attack patients who had the proprietary PCoFI diagnostic measurement of microvascular obstruction (MVO) made during a stenting procedure, when compared to the reference standard diagnosis by cardiac MRI in the subsequent days. Phase 1 included 19 patients enrolled across 5 US and 3 European sites. MOCA II follows the FIH MOCA I study and primarily aims to validate the threshold value of the proprietary PCoFI measurement for diagnosing MVO in the setting of primary angioplasty compared to cardiac MRI. This milestone achievement, which was confirmed by the study’s independent DSMB (Data and Safety Monit

Agendia to Present New Data Demonstrating the Expanded Clinical Utility of MammaPrint ® and BluePrint ® at the 2026 ESMO Breast Cancer Annual Congress30.4.2026 14:00:00 EEST | Press release

Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new data at the 2026 European Society for Medical Oncology (ESMO) Annual Congress on Breast Cancer, taking place May 6-8 in Berlin, Germany. The company will present two posters featuring data from the prospective FLEX Study and an independent post hoc analysis of the landmark MINDACT trial that underscore the prognostic value of MammaPrint® + BluePrint® in early-stage breast cancer (EBC). Poster #65P | Thursday, May 7, 13:15 – 14:15 p.m. CEST | Presenter: Elena Shagisultanova Prognostic Performance of MammaPrint in Patients with Small T1a, b, and c Node-Negative Early Breast Cancer A retrospective analysis from the FLEX Study involving 4,349 patients highlights the biological heterogeneity within small, node-negative (T1a, b, and c) tumors – a group that typically has favorable outcomes. MammaPrint (MP) identified a High Risk 2 (H2) subset, representing 10% of all patients and 5% of those

The Biggest Predictor of Business Growth Is Behavior30.4.2026 10:00:00 EEST | Press release

IDEO, the global design and innovation company, today announced the IDEO Innovation Quotient (IDEO IQ), a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. Those with the highest IDEO IQ scores earned nearly $20 billion in profit last year—50% higher than average and three times more than those ranked at the bottom. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429978890/en/ The IDEO Innovation Quotient (IDEO IQ) is a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. The IDEO IQ surveyed 266 leaders in product and innovation roles at 100 of the world’s largest companies across the Media & Technology, Healthcare, and Consumer Goods sectors. The report is the first of its kind to draw a direct line between how companies operate internally and their financial performance. Companies were surve

Suzano Sells 12.7 Million Tonnes of Pulp for the First Time in Its History30.4.2026 01:22:00 EEST | Press release

Suzano(B3: SUZB3 | NYSE: SUZ), the world’s largest pulp producer, announces its results for the first quarter of 2026 (1Q26), achieving a new all‑time record in pulp sales. Over the 12‑month period from April 2025 to March 2026, the company sold 12.7 million tonnes of pulp, the highest volume ever recorded in its history. During the same period, Suzano also sold 1.7 million tonnes of paper across the packaging, printing and writing, specialty, and tissue segments. This unprecedented sales level mainly reflects the increase in production capacity following the start‑up of the Ribas do Rio Pardo pulp mill in the state of Mato Grosso do Sul, as well as Suzano’s strong operational efficiency across its production lines and supply chains, serving customers in more than 100 countries worldwide. In the first quarter of 2026, Suzano sold a total of 3.2 million tonnes, comprising 2.8 million tonnes of pulp and 378 thousand tonnes of paper. Net revenue amounted to BRL 11.0 billion, while adjuste

The Estée Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN29.4.2026 23:30:00 EEST | Press release

The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429495879/en/ 111SKIN's Reparative Collection Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients’ healing time following procedures. At the heart of the brand is its innovative NAC Y2™, a pioneering complex designed to support skin repair and maintain a healthy, radiant and resilient complexion. Building on the foundation of this clinical expertise, 111SKIN has developed a portfolio of more than 30 products, anchored by its Black Diamond and Reparative collections and priced from $50 to $1,000. “Skin care is entering a new phase, shaped by the convergence of procedures, longevity and b

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye